Effect of Epidural Catheter Retention Depth on Labor Analgesia Performed in DPE Combined With PIEB Model
Launched by GENERAL HOSPITAL OF NINGXIA MEDICAL UNIVERSITY · Sep 17, 2024
Trial Information
Current as of August 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how the depth at which an epidural catheter is placed can affect pain relief during labor. The goal is to find the best depth that allows for quicker pain relief while also minimizing any problems related to the catheter itself. This study is specifically focusing on healthy pregnant women who are between 18 and 45 years old, are at least 37 weeks pregnant, and want to use an epidural for pain management during labor. To join the study, participants should be experiencing moderate to severe pain from contractions and have no serious health issues that would make epidural anesthesia unsafe for them.
If you decide to participate, you can expect to receive an epidural for labor pain relief while being monitored closely for any side effects. The study is currently looking for new participants, so if you meet the eligibility criteria and are interested, this could be a good opportunity to contribute to important research that aims to improve pain management during childbirth.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Those aged 18 to 45 years old;
- • 2. Pregnancy lasts for 37 to 42 weeks;
- • 3. Single healthy pregnant women with cervical dilation \< 3.0 cm who wish to use epidural labor analgesia;
- • 4. The NRS score of uterine contraction pain is \> 3;
- • 5. ASA grade I-II;
- • 6. BMI ≤ 40 kg/m².
- Exclusion Criteria:
- • 1. Those with contraindications to intraspinal anesthesia;
- • 2. Those with a history of allergy to local anesthetics and opioids;
- • 3. Pregnancy diseases (such as pregnancy-induced hypertension, preeclampsia or gestational diabetes, etc.);
- • 4. Known fetal abnormalities or situations associated with an increased risk of cesarean section;
- • 5. Patients who have taken opioids or sedatives within 4 hours before epidural analgesia.
About General Hospital Of Ningxia Medical University
The General Hospital of Ningxia Medical University is a leading healthcare institution dedicated to advancing medical research and patient care. As a prominent clinical trial sponsor, the hospital integrates cutting-edge research with its extensive clinical expertise to facilitate innovative studies across various medical fields. With a commitment to improving health outcomes, the General Hospital of Ningxia Medical University collaborates with researchers and healthcare professionals to conduct rigorous trials that adhere to the highest ethical and scientific standards, ultimately contributing to the advancement of medical knowledge and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yinchuan, Ningxia, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported